Dermatoscope for Skin Cancer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
City of Hope Medical Center, Duarte, CASkin CancerDermatoscope - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing the impact of an invention for early detection of skin cancer in stem cell transplant survivors and their primary care providers.

Eligible Conditions
  • Skin Cancer

Treatment Effectiveness

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: Up to 12 months

Baseline and 12 months
Impact of patient activation and education alone or with physician activation on change in skin cancer screening and health promotion practices
Up to 12 months
Downstream costs
Economic impact on patients - cost-effectiveness analysis
Economic impact on patients - sensitivity analysis
Impact of an e-learning teledermoscopy program compared with provision of print materials for identifying suspect lesions
Nevus

Trial Safety

Trial Design

3 Treatment Groups

Group III (PAE, physician, dermatoscope)
1 of 3
Group I (PAE)
1 of 3
Group II (PAE, physician)
1 of 3

Experimental Treatment

720 Total Participants · 3 Treatment Groups

Primary Treatment: Dermatoscope · No Placebo Group · N/A

Group III (PAE, physician, dermatoscope)Experimental Group · 6 Interventions: Educational Intervention, Educational Intervention (Physician), Questionnaire Administration, Computer-Assisted Intervention, Dermatoscope, Text Message · Intervention Types: Other, Other, Other, Other, Device, Other
Group I (PAE)Experimental Group · 3 Interventions: Educational Intervention, Questionnaire Administration, Text Message · Intervention Types: Other, Other, Other
Group II (PAE, physician)Experimental Group · 4 Interventions: Educational Intervention, Educational Intervention (Physician), Questionnaire Administration, Text Message · Intervention Types: Other, Other, Other, Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 12 months

Who is running the clinical trial?

City of Hope Medical CenterLead Sponsor
524 Previous Clinical Trials
2,248,955 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,153 Previous Clinical Trials
41,161,907 Total Patients Enrolled
Saro H ArmenianPrincipal InvestigatorCity of Hope Comprehensive Cancer Center
3 Previous Clinical Trials
732 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You had a hematopoietic stem cell transplant (HCT) 2 to 5 years ago (plus or minus 3 months).

Frequently Asked Questions

How many individuals have been recruited to take part in this experiment?

"Indeed, the clinicaltrials.gov database suggests that this research is actively looking for volunteers. The trial was initially published on October 30th 2020 and its information has since been updated on May 23rd 2022. 720 participants are needed from a single site to fulfill their quota." - Anonymous Online Contributor

Unverified Answer

Is there currently a call for volunteers for this research project?

"Affirmative, clinicaltrials.gov attests to the ongoing recruitment for this trial which was inaugurated on October 30th 2020 and most recently refreshed on May 23rd 2022. To date, a total of 720 patients have need to be enrolled from 1 medical facility." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.